Annual CFI
$131.71 M
+$229.77 M+234.30%
December 1, 2024
Summary
- As of March 12, 2025, RCKT annual cash flow from investing activities is $131.71 million, with the most recent change of +$229.77 million (+234.30%) on December 1, 2024.
- During the last 3 years, RCKT annual CFI has risen by +$112.85 million (+598.59%).
- RCKT annual CFI is now at all-time high.
Performance
RCKT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$37.87 M
-$116.79 M-147.99%
December 1, 2024
Summary
- As of March 12, 2025, RCKT quarterly cash flow from investing activities is -$37.87 million, with the most recent change of -$116.79 million (-147.99%) on December 1, 2024.
- Over the past year, RCKT quarterly CFI has increased by +$102.93 million (+73.10%).
- RCKT quarterly CFI is now -144.00% below its all-time high of $86.08 million, reached on March 31, 2018.
Performance
RCKT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$131.71 M
+$102.93 M+357.76%
December 1, 2024
Summary
- As of March 12, 2025, RCKT TTM cash flow from investing activities is $131.71 million, with the most recent change of +$102.93 million (+357.76%) on December 1, 2024.
- Over the past year, RCKT TTM CFI has increased by +$229.77 million (+234.30%).
- RCKT TTM CFI is now -18.31% below its all-time high of $161.22 million, reached on March 31, 2018.
Performance
RCKT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
RCKT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +234.3% | +73.1% | +234.3% |
| 3 y3 years | +598.6% | -178.5% | +300.0% |
| 5 y5 years | +437.6% | -178.5% | +300.0% |
RCKT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +234.3% | -148.0% | +73.1% | at high | +234.3% |
| 5 y | 5-year | at high | +234.3% | -148.0% | +73.1% | at high | +185.9% |
| alltime | all time | at high | +234.3% | -144.0% | +73.1% | -18.3% | +185.9% |
Rocket Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $131.71 M(-234.3%) | -$37.87 M(-148.0%) | $131.71 M(+357.8%) |
| Sep 2024 | - | $78.92 M(+41.9%) | $28.77 M(-1619.9%) |
| Jun 2024 | - | $55.62 M(+58.8%) | -$1.89 M(-92.8%) |
| Mar 2024 | - | $35.03 M(-124.9%) | -$26.31 M(-73.2%) |
| Dec 2023 | -$98.07 M(+41.5%) | -$140.81 M(-391.8%) | -$98.07 M(+48.9%) |
| Sep 2023 | - | $48.25 M(+54.6%) | -$65.85 M(-27.4%) |
| Jun 2023 | - | $31.21 M(-185.0%) | -$90.64 M(+110.5%) |
| Mar 2023 | - | -$36.72 M(-66.2%) | -$43.05 M(-37.9%) |
| Dec 2022 | -$69.33 M(-467.7%) | -$108.58 M(-562.8%) | -$69.33 M(-223.5%) |
| Sep 2022 | - | $23.46 M(-70.2%) | $56.12 M(+287.9%) |
| Jun 2022 | - | $78.79 M(-225.1%) | $14.47 M(-196.7%) |
| Mar 2022 | - | -$62.99 M(-473.5%) | -$14.97 M(-179.4%) |
| Dec 2021 | $18.85 M(-119.5%) | $16.86 M(-192.7%) | $18.85 M(-135.9%) |
| Sep 2021 | - | -$18.19 M(-136.9%) | -$52.47 M(-46.7%) |
| Jun 2021 | - | $49.35 M(-269.2%) | -$98.48 M(-35.7%) |
| Mar 2021 | - | -$29.17 M(-46.4%) | -$153.26 M(+58.7%) |
| Dec 2020 | -$96.59 M(+147.6%) | -$54.46 M(-15.2%) | -$96.59 M(+418.9%) |
| Sep 2020 | - | -$64.19 M(+1081.1%) | -$18.61 M(-123.1%) |
| Jun 2020 | - | -$5.43 M(-119.8%) | $80.76 M(-298.5%) |
| Mar 2020 | - | $27.50 M(+16.9%) | -$40.69 M(+4.3%) |
| Dec 2019 | -$39.01 M | $23.51 M(-33.2%) | -$39.01 M(-10.3%) |
| Sep 2019 | - | $35.18 M(-127.7%) | -$43.48 M(-46.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$126.88 M(-534.9%) | -$81.64 M(+31.3%) |
| Mar 2019 | - | $29.18 M(+53.2%) | -$62.17 M(+1079.3%) |
| Dec 2018 | -$5.27 M(-107.0%) | $19.05 M(-738.2%) | -$5.27 M(-110.3%) |
| Sep 2018 | - | -$2.98 M(-97.2%) | $51.42 M(-5.5%) |
| Jun 2018 | - | -$107.41 M(-224.8%) | $54.41 M(-66.3%) |
| Mar 2018 | - | $86.08 M(+13.6%) | $161.22 M(+114.9%) |
| Dec 2017 | $75.02 M(-213.6%) | $75.75 M(<-9900.0%) | $75.02 M(-274.4%) |
| Sep 2017 | - | -$1000.00(-99.8%) | -$43.01 M(+13.0%) |
| Jun 2017 | - | -$598.00 K(+356.5%) | -$38.08 M(-29.3%) |
| Mar 2017 | - | -$131.00 K(-99.7%) | -$53.85 M(-18.5%) |
| Dec 2016 | -$66.06 M(+108.6%) | -$42.28 M(-957.5%) | -$66.06 M(+153.9%) |
| Sep 2016 | - | $4.93 M(-130.1%) | -$26.02 M(-56.9%) |
| Jun 2016 | - | -$16.37 M(+32.6%) | -$60.35 M(+37.1%) |
| Mar 2016 | - | -$12.34 M(+451.0%) | -$44.02 M(+39.0%) |
| Dec 2015 | -$31.68 M(<-9900.0%) | -$2.24 M(-92.4%) | -$31.68 M(+7.6%) |
| Sep 2015 | - | -$29.41 M(>+9900.0%) | -$29.43 M(>+9900.0%) |
| Jun 2015 | - | -$30.00 K(<-9900.0%) | -$30.00 K(<-9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $0.00(-100.0%) | - | - |
| Dec 2012 | $3000.00 | - | - |
FAQ
- What is Rocket Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual CFI year-on-year change?
- What is Rocket Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly CFI year-on-year change?
- What is Rocket Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals TTM CFI year-on-year change?
What is Rocket Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of RCKT is $131.71 M
What is the all time high annual CFI for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual cash flow from investing activities is $131.71 M
What is Rocket Pharmaceuticals annual CFI year-on-year change?
Over the past year, RCKT annual cash flow from investing activities has changed by +$229.77 M (+234.30%)
What is Rocket Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of RCKT is -$37.87 M
What is the all time high quarterly CFI for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly cash flow from investing activities is $86.08 M
What is Rocket Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, RCKT quarterly cash flow from investing activities has changed by +$102.93 M (+73.10%)
What is Rocket Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of RCKT is $131.71 M
What is the all time high TTM CFI for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high TTM cash flow from investing activities is $161.22 M
What is Rocket Pharmaceuticals TTM CFI year-on-year change?
Over the past year, RCKT TTM cash flow from investing activities has changed by +$229.77 M (+234.30%)